Last Price$254.01.2%
Market Cap$21.2B
LTM FCF to Net Income
146.8%
5Y avg
152.7%
Medical - Diagnostics & Research industry
median
87.3%
Stock quality & Intrinsic value
6/10
1.4% undervalued
Laboratory Corporation of America Holdings FCF to Net Income
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF to Net Income | 122.1% | 124.4% | 119.5% | 118.8% | 134.4% | 134.6% | 132.5% | 133.2% | 113.7% | 107.1% | 104.5% | 165.9% | 122.3% | 89.8% | 104.7% | 126.6% | 112.6% | 111.3% | 115.1% | 230.5% |
Overvalued or undervalued?
Check the intrinsic value for LH
and see if it's the right time to invest.
Laboratory Corporation of America Holdings (LH) FCF to Net Income comparison analysis
General
LTM FCF to Net Income
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Laboratory Corporation of America HoldingsLH
146.8%
(18.3%)
(65.8%)
3.4%
Median Peer Set
101.7%
(0.3%)
(2.0%)
15.2%
Danaher CorporationDHR
188.3%
(0.1%)
(17.9%)
16.3%
IQVIA Holdings Inc.IQV
154.0%
2.8%
2.4%
8.9%
Thermo Fisher Scientific Inc.TMO
114.7%
(4.6%)
(12.4%)
14.0%
Agilent Technologies, Inc.A
111.9%
(4.7%)
5.0%
19.8%
Quest Diagnostics IncorporatedDGX
103.3%
(6.4%)
(6.5%)
9.2%
Mettler-Toledo International Inc.MTD
100.2%
2.2%
12.7%
22.3%
Waters CorporationWAT
97.1%
(0.5%)
(7.9%)
21.7%
IDEXX Laboratories, Inc.IDXX
89.9%
8.7%
25.2%
23.1%
Natera, Inc.NTRA
15.5%
32.0%
(32.1%)
(40.2%)
Illumina, Inc.ILMN
(49.4%)
(2.9%)
4.6%
(28.0%)
LH key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 3,084.8 0.0% | 3,327.6 7.9% | 3,590.8 7.9% | 4,068.2 13.3% | 4,505.2 10.7% | 4,694.7 4.2% | 5,003.9 6.6% | 5,542.3 10.8% | 5,671.4 2.3% | 5,808.3 2.4% | 6,011.6 3.5% | 8,680.1 44.4% | 9,641.8 11.1% | 10,441.4 8.3% | 11,333.4 8.5% | 11,554.8 2.0% | 13,978.5 21.0% | 16,120.9 15.3% | 14,876.8 (7.7%) | 12,161.6 (18.3%) |
| Cost of Goods Sold (COGS) | 1,795.5 | 1,937.3 | 2,061.4 | 2,377.0 | 2,631.4 | 2,723.8 | 2,906.1 | 3,267.6 | 3,421.7 | 3,585.1 | 3,808.5 | 5,776.8 | 6,461.3 | 6,977.4 | 8,157.0 | 8,302.3 | 9,025.7 | 10,496.6 | 10,491.7 | 8,796.7 |
% margin | 1,289.3 41.8% | 1,390.3 41.8% | 1,529.4 42.6% | 1,691.2 41.6% | 1,873.8 41.6% | 1,970.9 42.0% | 2,097.8 41.9% | 2,274.7 41.0% | 2,249.7 39.7% | 2,223.2 38.3% | 2,203.1 36.6% | 2,903.3 33.4% | 3,180.5 33.0% | 3,464.0 33.2% | 3,176.4 28.0% | 3,252.5 28.1% | 4,952.8 35.4% | 5,624.3 34.9% | 4,385.1 29.5% | 3,364.9 27.7% |
| Operating Expenses | 691.8 | 755.3 | 831.3 | 863.6 | 1,030.9 | 1,021.5 | 1,107.0 | 1,245.4 | 1,200.9 | 1,210.5 | 1,274.9 | 1,786.5 | 1,809.7 | 2,028.9 | 1,802.6 | 1,867.7 | 2,004.7 | 2,321.7 | 2,255.9 | 2,639.3 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 |
| Selling, General & Administrative Expenses (SG&A) | 649.1 | 703.9 | 779.1 | 808.7 | 935.1 | 958.9 | 1,034.3 | 1,159.6 | 1,114.6 | 1,128.8 | 1,198.2 | 1,622.0 | 1,630.2 | 1,812.4 | 1,570.9 | 1,624.5 | 1,729.3 | 1,952.1 | 1,996.6 | 2,021.4 |
% margin | 598.4 19.4% | 618.1 18.6% | 697.1 19.4% | 777.0 19.1% | 842.9 18.7% | 935.9 19.9% | 978.8 19.6% | 948.4 17.1% | 1,023.5 18.0% | 990.9 17.1% | 910.4 15.1% | 1,002.9 11.6% | 1,312.4 13.6% | 1,364.2 13.1% | 1,325.7 11.7% | 1,330.2 11.5% | 2,445.4 17.5% | 3,259.5 20.2% | 1,773.9 11.9% | 725.6 6.0% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 2.5 | 1.6 | 1.1 | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.8 | 10.3 | 10.2 | 8.9 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 72.0 | 62.9 | 70.0 | 87.5 | 94.5 | 103.7 | 109.5 | 274.9 | 219.1 | 235.1 | 244.2 | 240.7 | 207.4 | 212.1 | 180.3 | 199.6 |
| Pre-tax Income | 615.3 | 640.7 | 720.9 | 802.3 | 772.4 | 884.6 | 915.6 | 866.1 | 944.2 | 915.6 | 826.7 | 732.1 | 1,105.5 | 1,134.9 | 1,268.3 | 1,104.9 | 2,219.1 | 3,126.6 | 1,582.6 | 568.9 |
% effective tax rate | 252.3 41.0% | 254.5 39.7% | 289.3 40.1% | 325.5 40.6% | 307.9 39.9% | 329.0 37.2% | 344.0 37.6% | 333.0 38.4% | 359.4 38.1% | 340.2 37.2% | 314.1 38.0% | 294.1 40.2% | 372.3 33.7% | (139.1) (12.3%) | 384.4 30.3% | 280.0 25.3% | 662.1 29.8% | 747.1 23.9% | 302.0 19.1% | 188.5 33.1% |
% margin | 363.0 11.8% | 386.2 11.6% | 431.6 12.0% | 476.8 11.7% | 464.5 10.3% | 543.3 11.6% | 558.2 11.2% | 519.7 9.4% | 583.1 10.3% | 573.8 9.9% | 511.2 8.5% | 436.9 5.0% | 732.1 7.6% | 1,268.2 12.1% | 883.7 7.8% | 823.8 7.1% | 1,556.1 11.1% | 2,377.3 14.7% | 1,279.1 8.6% | 418.0 3.4% |
| EPS | 2.60 | 2.89 | 3.48 | 4.08 | 4.60 | 4.98 | 5.45 | 5.31 | 6.24 | 6.70 | 6.03 | 4.42 | 7.14 | 12.39 | 8.71 | 8.41 | 15.99 | 24.58 | 14.04 | 4.80 |
| Diluted EPS | 2.45 | 2.71 | 3.24 | 3.93 | 4.60 | 4.98 | 5.29 | 5.11 | 5.99 | 6.25 | 5.91 | 4.34 | 7.02 | 12.21 | 8.61 | 8.36 | 15.88 | 24.38 | 13.96 | 4.77 |
% margin | 790.2 25.6% | 784.8 23.6% | 853.1 23.8% | 990.4 24.3% | 1,035.7 23.0% | 1,140.8 24.3% | 1,189.2 23.8% | 1,180.9 21.3% | 1,259.9 22.2% | 1,238.5 21.3% | 1,175.6 19.6% | 1,576.8 18.2% | 1,809.6 18.8% | 1,845.8 17.7% | 2,064.6 18.2% | 2,116.9 18.3% | 3,251.5 23.3% | 4,278.7 26.5% | 1,954.4 13.1% | 1,349.4 11.1% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Laboratory Corporation of America Holdings's FCF to Net Income?
As of today, Microsoft Corp's last 12-month FCF to Net Income is 146.8%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual FCF to Net Income for Laboratory Corporation of America Holdings have been 135.2% over the past three years, and 160.3% over the past five years.
2) Is Laboratory Corporation of America Holdings's FCF to Net Income Good?
As of today, Laboratory Corporation of America Holdings's FCF to Net Income is 146.8%, which is higher than industry median of 87.3%. It indicates that Laboratory Corporation of America Holdings's FCF to Net Income is Good.